A strategy of screening and binding analysis of bioactive components from traditional Chinese medicine based on surface plasmon resonance biosensor
2021 · Journal of Pharmaceutical Analysis · 47 citations
https://doi.org/10.1016/j.jpha.2021.11.006
W
Wei‐Heng Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
801
Citations
17
h-index
22
i10-index
Wei‐Heng Xu is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Bioactive natural compounds & Liver physiology and pathology. The author has an h-index of 17, co-authored 31 publications.
ORCID: 0000-0003-1264-0761Papers by this author
worksA novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways
2016 · Acta Pharmacologica Sinica · 42 citations
https://doi.org/10.1038/aps.2016.104
ARG1 as a promising biomarker for sepsis diagnosis and prognosis: evidence from WGCNA and PPI network
2022 · Hereditas · 21 citations
https://doi.org/10.1186/s41065-022-00240-1
ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis
2024 · Heliyon · 5 citations
https://doi.org/10.1016/j.heliyon.2024.e38608
Anti-sepsis effects of Dahuang Mudan decoction and its disassembled prescriptions
2024 · Journal of Ethnopharmacology · 4 citations
https://doi.org/10.1016/j.jep.2024.119248
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat